TRPV3 is a temperature-sensitive vanilloid receptor-like protein
George Davey Smith(University of Bristol), Janet L. Davis(University of Miami), Jean‐Philippe Walhin(GlaxoSmithKline (United Kingdom)), Martin J. Gunthorpe(GlaxoSmithKline (United Kingdom)), P. Facer(London Postgraduate Medical and Dental Education), Julie Egerton(GlaxoSmithKline (United Kingdom)), Lezanne Ooi(University of Wollongong), Praveen Anand(Hammersmith Hospital), Peter J. Reilly(Texas A&M University School of Law), James E. Wright(GlaxoSmithKline (United Kingdom)), Jeffrey C. Jerman(GlaxoSmithKline (United Kingdom)), D Smart(GlaxoSmithKline (United Kingdom)), Philip D. Hayes(GlaxoSmithKline (United Kingdom)), Rosemary E. Kelsell(GlaxoSmithKline (United Kingdom)), Andrew D. Randall(GlaxoSmithKline (United Kingdom))
Cited by 851
Related Papers
A reference panel of 64,976 haplotypes for genotype imputation
|Nature Genetics|2016|3.3k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k
Evaluating the potential role of pleiotropy in Mendelian randomization studies
|Human Molecular Genetics|2018|1.7k